Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | SLC6A6 | P31641 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | APP | P05067 | 1/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | PDE4A | P27815 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CA5A | P35218 | 2/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | NT5E | P21589 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Taurine SCHEMBL30191395 | 1.00 | — | — | |
| Taurine SCHEMBL30179154 | 1.00 | — | — | |
| Taurine SCHEMBL23068 | 1.00 | — | — | |
| Taurine SCHEMBL2422017 | 0.97 | — | — | |
| Taurine SCHEMBL8052521 | 0.97 | BLM (0.93) | BLMLMNASLC6A6CYP2C19APP | |
| Taurine SCHEMBL15194490 | 0.97 | — | — | |
| Taurine SCHEMBL10626136 | 0.97 | — | — | |
| Taurine SCHEMBL688316 | 0.97 | — | — | |
| Taurine SCHEMBL11449240 | 0.97 | — | — | |
| Taurine SCHEMBL1100954 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114002421-B | Application of exosome metabolite as bipolar affective disorder marker | 佛山市第三人民医院(佛山市精神卫生中心) | 2022-04-05 | — | — | CN | claimed |
| CN-114002421-A | Application of exosome metabolite as bipolar affective disorder marker | 佛山市第三人民医院(佛山市精神卫生中心) | 2022-02-01 | — | — | CN | claimed |
| US-20110092636-A1 | WATER SWELLABLE AND WATER SOLUBLE POLYMERS AND USE THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-04-21 | — | — | US | claimed |
| JP-5097666-A | — | — | None | — | — | JP | disclosed |
| US-20250177330-A1 | Use of Thiol Compounds to Treat Neurological Disease | MERCAPTOR DISCOVERIES, INC. | 2025-06-05 | — | — | US | disclosed |
| US-12128014-B2 | Use of thiol compounds to treat neurological disease | MERCAPTOR DISCOVERIES, INC. (US) | 2024-10-29 | — | — | US | disclosed |
| EP-3615013-B1 | THIOL COMPOUNS FOR TREATING ACUTE TRAUMATIC BRAIN INJURY | MERCAPTOR DISCOVERIES INC (US) | 2024-08-14 | — | — | EP | disclosed |
| WO-2024099769-A1 | A METHOD OF EARLY PREDICTION OF RISK OF PRE-TERM PRE-ECLAMPSIA IN SPECIFIC POPULATION COHORTS | Metabolomic Diagnostics Limited (IE) | 2024-05-16 | — | — | WO | disclosed |
| US-11958109-B2 | Three-dimensional printing | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2024-04-16 | — | — | US | disclosed |
| WO-2024058984-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2024-03-21 | — | — | WO | disclosed |
| EP-4199726-A1 | BIOLOGICAL-BASED CATALYST TO DELAY PLANT DEVELOPMENT PROCESSES | Crowpierce Technologies, LLC (US) | 2023-06-28 | — | — | EP | disclosed |
| EP-1158972-A1 | TREATMENT OF HYPERTENSION WITH COMPOUNDS THAT INHIBIT THE DESTRUCTION OF ENKEPHALINS OR ENDORPHINS | Ehrenpreis, Seymour (US) | 2001-12-05 | — | — | EP | disclosed |
| EP-1149878-A2 | Ink, ink-jet ink, method for reducing kogation on surface of heater of ink-jet recording head, method for ink-jet recording, ink-jet recording apparatus, recording unit and method for prolonging ink-jet recording head life | CANON KABUSHIKI KAISHA (JP) | 2001-10-31 | — | — | EP | disclosed |
| US-6218352-B1 | STORAGE STABILITY; WATER SOLUBILITY; AS BLEACHING AGENT | ORIENTAL CHEMICAL INDUSTRIES (KR) | 2001-04-17 | — | — | US | disclosed |
| US-6207190-B1 | SYNERGISTIC MIXTURE TO REDUCE OCULAR PRESSURE AND IMPROVE VASCULAR HEALTH COMPRISING FOLIC ACID, A MAGNESIUM SALT, ALPHA-TOCOPHEROL, ASCORBATE AND ALPHA-LIPOIC ACID | CHRONORX, LLC | 2001-03-27 | — | — | US | disclosed |
| WO-2000041686-A1 | TREATMENT OF HYPERTENSION WITH COMPOUNDS THAT INHIBIT THE DESTRUCTION OF ENKEPHALINS OR ENDORPHINS | EHRENPREIS SEYMOUR (US) | 2000-07-20 | — | — | WO | disclosed |
| US-5539024-A | REACTION PRODUCT OF PERFLUOROALKYL SULFONAMIDE, OXYETHYLENE COMPOUND SUCH AS POLYETHERESTER, AND EPOXY COMPOUND SUCH AS NOVOLAC GLYCIDYL ETHER, PROTECTIVE COATINGS FOR PAPER, TEXTILES, LEATHER, MINERALS | BAYER AKTIENGESELLSCHAFT (DE) | 1996-07-23 | — | — | US | disclosed |
| JP-H0597666-A | AMPHOTERIC ION COMPOUND AND N-HALO DERIVATIVE OF THE SAME USED FOR THERAPY OF CLINICAL SYMPTOM | DERMA SYST LAB LTD | 1993-04-20 | — | — | JP | disclosed |
| US-4565830-A | TAURINE | AZUMA JUN ICHI (JP) | 1986-01-21 | — | — | US | disclosed |
| US-4563470-A | TREATMENT OF METAL DEFICIENCIES | LES LABORATORIES MERAM (FR) | 1986-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12128014-B2 | Use of thiol compounds to treat neurological disease | TST, NLN, SLC7A11 | BLM 4022/4885LMNA 4730/4885SLC6A6 105/4885 |
| US-20250177330-A1 | Use of Thiol Compounds to Treat Neurological Disease | TST, NLN, SLC7A11 | BLM 4022/4885LMNA 4730/4885SLC6A6 105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.